
    
      A total of 20 patients will be included to wear the Sunbit system during the time of 4 weeks.
      After this 4 weeks Sunbit will be recollected and data in the form of UV Indices will be
      extracted and analyzed.

      Patients will be recruited in the Department of Dermatology of the University Hospital
      ZÃ¼rich. The target population comprises patients with a high risk of melanoma and
      non-melanoma skin cancer, thus especially patients with an immunosuppressive therapy due to
      organ transplantation.
    
  